Solicitation of Nominations for Membership To Serve on the Centers for Disease Control and Prevention (CDC)/Health Resources and Services Administration (HRSA) Advisory Committee on HIV, Viral Hepatitis and Sexually Transmitted Disease (STD) Prevention and Treatment, 69754-69755 [2019-27301]
Download as PDF
<![CDATA[
69754
Federal Register / Vol. 84, No. 244 / Thursday, December 19, 2019 / Notices
Refer to the NACNHSC website listed
above for all current and updated
information concerning the CY 2020
NACNHSC meetings, including draft
agendas and meeting materials that will
be posted 14 calendar days before each
meeting. Members of the public will
have the opportunity to provide
comments. Public participants may
submit written statements in advance of
the scheduled meeting(s). Oral
comments will be honored in the order
they are requested and may be limited
as time allows.
Requests to submit a written
statement or make oral comments to the
NACNHSC should be sent to Diane
Fabiyi-King via email at
BHWNACNHSC@hrsa.gov at least 5
business days before the meeting
date(s). Individuals who need special
assistance or another reasonable
accommodation should notify Diane
Fabiyi-King using the contact
information listed above at least 10
business days before the meeting(s) they
wish to attend. Since all in-person
meetings occur in a federal government
building, attendees must go through a
security check to enter the building.
Non-U.S. Citizen attendees must notify
HRSA of their planned attendance at
least 20 business days prior to the
meeting in order to facilitate their entry
into the building. All attendees are
required to present government-issued
identification prior to entry.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2019–27357 Filed 12–18–19; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Solicitation of Nominations for
Membership To Serve on the Centers
for Disease Control and Prevention
(CDC)/Health Resources and Services
Administration (HRSA) Advisory
Committee on HIV, Viral Hepatitis and
Sexually Transmitted Disease (STD)
Prevention and Treatment
HRSA, Department of Health
and Human Services (HHS).
ACTION: Request for nominations.
lotter on DSKBCFDHB2PROD with NOTICES
AGENCY:
HRSA is seeking nominations
of qualified candidates for consideration
for appointment as members of the
CDC/HRSA Advisory Committee on
HIV, Viral Hepatitis and STD Prevention
and Treatment (CHACHSPT).
CHACHSPT advises the HHS Secretary,
SUMMARY:
VerDate Sep<11>2014
19:13 Dec 18, 2019
Jkt 250001
the CDC Director, and the HRSA
Administrator on objectives, strategies,
policies, and priorities for HIV, viral
hepatitis, and STD prevention and
treatment efforts. These include
surveillance of HIV infection, viral
hepatitis, other STDs, and related
behaviors; epidemiologic, behavioral,
health services, and laboratory research
on HIV, viral hepatitis, and other STDs;
identification of policy issues related to
HIV/viral hepatitis/STD professional
education, patient healthcare delivery,
and prevention services; agency policies
about prevention, treatment, healthcare
delivery, and research and training
relating to HIV, viral hepatitis and other
STDs; strategic issues influencing the
ability of CDC and HRSA to fulfill their
missions of providing prevention and
treatment services; programmatic efforts
to prevent and treat HIV, viral hepatitis,
and other STDs; and support to the
agencies in their development of
responses to emerging health needs
related to HIV, viral hepatitis, and other
STDs.
DATES: HRSA will receive written
nominations for CHACHSPT on a
continuous basis.
ADDRESSES: Nomination packages must
be submitted via email at
CHACAdvisoryComm@hrsa.gov.
FOR FURTHER INFORMATION CONTACT:
Email chacadvidorycomm@hrsa.gov. A
copy of the CHACHSPT charter and list
of the current membership may be
obtained by accessing the CHACHSPT
website at https://www.cdc.gov/maso/
facm/facmchachspt.html.
SUPPLEMENTARY INFORMATION: The
Secretary of HHS, and by delegation, the
CDC Director and the HRSA
Administrator, are authorized by the
PHS Act to: (1) Conduct, encourage,
cooperate with, and assist other
appropriate public health authorities,
scientific institutions, and scientists in
the conduct of research, investigations,
experiments, demonstrations, and
studies relating to the causes, diagnosis,
treatment, control, and prevention of
physical and mental diseases, and other
impairments; (2) assist states and their
political subdivisions in preventing,
suppressing, and treating communicable
diseases and other preventable
conditions and in promoting health and
well-being; (3) assist public and nonprofit private entities in preventing,
controlling and treating STDs, including
HIV; (4) improve health and achieve
health equity through access to quality
services and a skilled health workforce
and innovative programs; (5) support
healthcare services to persons living
with or at risk for HIV, viral hepatitis,
and other STDs; and (6) advance the
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
education of health professionals and
the public about HIV, viral hepatitis,
and other STDs.
CHACHSPT meets two times each
calendar year, or at the discretion of the
Designated Federal Officer in
consultation with the CHACHSPT cochairs.
Nominations: HRSA is requesting
nominations for voting members to
serve as Special Government Employees
(SGEs) on CHACHSPT. The Secretary of
HHS appoints CHACHSPT members
with the expertise needed to fulfill the
duties of the Advisory Committee.
Nominees are sought to provide a
balance of diverse experiences and
expertise. The Secretary of HHS or his
designee shall select members of the
CHACHSPT with knowledge in the
fields of public health; epidemiology;
laboratory practice; immunology;
infectious diseases; behavioral health
and science including, but not limited,
to opioid use and related expertise;
health education; healthcare delivery;
state health programs; clinical care;
preventive health; medical education;
health services and clinical research;
and healthcare financing. In addition,
people with HIV and affected
populations, as well as state and local
health and education agencies, HIV/
viral hepatitis/STD community-based
organizations, and the ethics or religious
community are encouraged to submit
nomination packages for consideration.
Current federal employees will not be
considered. Interested applicants may
self-nominate or be nominated by
another individual or organization.
Individuals selected for appointment
to CHACHSPT will be invited to serve
for up to 4 years. Members appointed as
SGEs receive a stipend and
reimbursement for per diem and travel
expenses incurred for attending
CHACHSPT meetings and/or
conducting other business on behalf of
the CHACHSPT as authorized by 5
U.S.C. 5703 of the Federal Travel
Regulation for persons employed
intermittently in government service.
The following information must be
included in the package of materials
submitted for each individual
nominated for consideration:
• A letter of interest or personal
statement from the nominee stating how
their expertise would inform the work
of CHACHSPT;
• A biographical sketch of the
nominee (500 words or fewer);
• A copy of the nominee’s resume or
curriculum vitae; and
• The nominee’s contact information
(address, daytime telephone number,
and email address).
E:\FR\FM\19DEN1.SGM
19DEN1
69755
Federal Register / Vol. 84, No. 244 / Thursday, December 19, 2019 / Notices
Nomination packages may be
submitted directly by the individual
seeking nomination or by the person/
organization recommending the
candidate. HRSA will collect and retain
nomination packages to create a pool of
potential future CHACHSPT members.
When a vacancy occurs, HRSA will
review nomination packages and may
contact nominees at that time.
Nominations should be updated and
resubmitted every two years for
continuing consideration for
CHACHSPT vacancies.
Appointments shall be made without
discrimination on the basis of age,
ethnicity, gender, sexual orientation, or
cultural, religious, or socioeconomic
status.
Individuals who are selected for
appointment will be required to provide
detailed information regarding their
financial interests and, for example, any
work they do for the federal government
through research grants or contracts.
Disclosure of this information is
required in order for HRSA ethics
officials to determine whether there is a
conflict between the SGE’s public duties
as a member of CHACHSPT and their
private interests, including an
appearance of a loss of impartiality as
defined by federal laws and regulations,
and to identify any required remedial
action needed to address the potential
conflict.
Authority: CHACHSPT was established
under Section 222 of the Public Health
Service (PHS) Act, [42 U.S.C. 217a], as
amended. CHACHSPT is governed by the
provisions of the Federal Advisory
Committee Act, as amended, 5 U.S.C. App.,
which sets forth requirements for the
formation and use of advisory committees.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2019–27301 Filed 12–18–19; 8:45 am]
BILLING CODE 4165–15–P
Type of Collection: Revision.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
OMB No.: 0990–0452.
[Document Identifier: OS–0990–0452]
Agency Information Collection
Request. 60-Day Public Comment
Request
Office of the Secretary, HHS.
Notice.
AGENCY:
ACTION:
In compliance with the
requirement of the Paperwork
Reduction Act of 1995, the Office of the
Secretary (OS), Department of Health
and Human Services, is publishing the
following summary of a proposed
collection for public comment.
DATES: Comments on the ICR must be
received on or before February 18, 2020.
ADDRESSES: Submit your comments to
Sherrette.Funn@hhs.gov or by calling
(202) 795–7714.
FOR FURTHER INFORMATION CONTACT:
When submitting comments or
requesting information, please include
the document identifier 0990–0452–
60D, and project title for reference, to
Sherrette Funn, the Reports Clearance
Officer, Sherrette.funn@hhs.gov, or call
202–795–7714.
SUPPLEMENTARY INFORMATION: Interested
persons are invited to send comments
regarding this burden estimate or any
other aspect of this collection of
information, including any of the
following subjects: (1) The necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions; (2) the accuracy
of the estimated burden; (3) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(4) the use of automated collection
techniques or other forms of information
technology to minimize the information
collection burden.
Title of the Collection: Federal
Evaluation of Making Proud Choices!
(MPC!).
SUMMARY:
Abstract: The Office of Population
Affairs (OPA), U.S. Department of
Health and Human Services (HHS) is
requesting an extension with revision of
a currently approved information
collection (OMB No: 0990–0452). The
purpose of the revision is to complete
the nine-month follow-up data
collection for the Federal Evaluation of
Making Proud Choices! (MPC). The
evaluation is being conducted in 15
schools across four school districts
nationwide and will provide
information about program design,
implementation, and impacts through a
rigorous assessment of a highly popular
teen pregnancy prevention
curriculum—MPC. Clearance is
requested for three years. This revision
is necessary to complete the 9-month
post-baseline follow up data collection
after enrolling a fourth and final cohort
into the study. The follow-up survey
data will be used to determine program
effectiveness by comparing sexual
behavior outcomes, such as postponing
sexual activity, and reducing or
preventing sexual risk behaviors and
STDs and intermediate outcomes, such
as improving exposure, knowledge and
attitudes between treatment (program)
and control youth. The findings from
these analyses of program impacts will
be of interest to the general public, to
policymakers, and to schools and other
organizations interested in supporting a
comprehensive approach to teen
pregnancy prevention. The revision
request also updates the burden by
removing the second (15 months post
baseline) survey from the data
collection.
Type of Respondent: The follow-up
survey will be administered to study
participants, who will primarily be in
10th–12th grade at the time of the
follow-up survey.
lotter on DSKBCFDHB2PROD with NOTICES
ANNUALIZED BURDEN HOUR TABLE
Number of
respondents
Number of
responses per
respondents
Average
burden per
response
Forms
(if necessary)
Respondents
(if necessary)
Follow up survey (9-months post baseline) ......................
students ............
200
1
30/60
100
Total ...........................................................................
...........................
........................
1
........................
100
Terry Clark,
Office of the Secretary, Asst. Paperwork
Reduction Act Reports Clearance Officer.
[FR Doc. 2019–27376 Filed 12–18–19; 8:45 am]
BILLING CODE 4150–43–P
VerDate Sep<11>2014
19:13 Dec 18, 2019
Jkt 250001
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
E:\FR\FM\19DEN1.SGM
19DEN1
Total burden
hours
]]>Agencies
[Federal Register Volume 84, Number 244 (Thursday, December 19, 2019)]
[Notices]
[Pages 69754-69755]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-27301]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Solicitation of Nominations for Membership To Serve on the
Centers for Disease Control and Prevention (CDC)/Health Resources and
Services Administration (HRSA) Advisory Committee on HIV, Viral
Hepatitis and Sexually Transmitted Disease (STD) Prevention and
Treatment
AGENCY: HRSA, Department of Health and Human Services (HHS).
ACTION: Request for nominations.
-----------------------------------------------------------------------
SUMMARY: HRSA is seeking nominations of qualified candidates for
consideration for appointment as members of the CDC/HRSA Advisory
Committee on HIV, Viral Hepatitis and STD Prevention and Treatment
(CHACHSPT). CHACHSPT advises the HHS Secretary, the CDC Director, and
the HRSA Administrator on objectives, strategies, policies, and
priorities for HIV, viral hepatitis, and STD prevention and treatment
efforts. These include surveillance of HIV infection, viral hepatitis,
other STDs, and related behaviors; epidemiologic, behavioral, health
services, and laboratory research on HIV, viral hepatitis, and other
STDs; identification of policy issues related to HIV/viral hepatitis/
STD professional education, patient healthcare delivery, and prevention
services; agency policies about prevention, treatment, healthcare
delivery, and research and training relating to HIV, viral hepatitis
and other STDs; strategic issues influencing the ability of CDC and
HRSA to fulfill their missions of providing prevention and treatment
services; programmatic efforts to prevent and treat HIV, viral
hepatitis, and other STDs; and support to the agencies in their
development of responses to emerging health needs related to HIV, viral
hepatitis, and other STDs.
DATES: HRSA will receive written nominations for CHACHSPT on a
continuous basis.
ADDRESSES: Nomination packages must be submitted via email at
[email protected].
FOR FURTHER INFORMATION CONTACT: Email [email protected]. A
copy of the CHACHSPT charter and list of the current membership may be
obtained by accessing the CHACHSPT website at https://www.cdc.gov/maso/facm/facmchachspt.html.
SUPPLEMENTARY INFORMATION: The Secretary of HHS, and by delegation, the
CDC Director and the HRSA Administrator, are authorized by the PHS Act
to: (1) Conduct, encourage, cooperate with, and assist other
appropriate public health authorities, scientific institutions, and
scientists in the conduct of research, investigations, experiments,
demonstrations, and studies relating to the causes, diagnosis,
treatment, control, and prevention of physical and mental diseases, and
other impairments; (2) assist states and their political subdivisions
in preventing, suppressing, and treating communicable diseases and
other preventable conditions and in promoting health and well-being;
(3) assist public and non-profit private entities in preventing,
controlling and treating STDs, including HIV; (4) improve health and
achieve health equity through access to quality services and a skilled
health workforce and innovative programs; (5) support healthcare
services to persons living with or at risk for HIV, viral hepatitis,
and other STDs; and (6) advance the education of health professionals
and the public about HIV, viral hepatitis, and other STDs.
CHACHSPT meets two times each calendar year, or at the discretion
of the Designated Federal Officer in consultation with the CHACHSPT co-
chairs.
Nominations: HRSA is requesting nominations for voting members to
serve as Special Government Employees (SGEs) on CHACHSPT. The Secretary
of HHS appoints CHACHSPT members with the expertise needed to fulfill
the duties of the Advisory Committee. Nominees are sought to provide a
balance of diverse experiences and expertise. The Secretary of HHS or
his designee shall select members of the CHACHSPT with knowledge in the
fields of public health; epidemiology; laboratory practice; immunology;
infectious diseases; behavioral health and science including, but not
limited, to opioid use and related expertise; health education;
healthcare delivery; state health programs; clinical care; preventive
health; medical education; health services and clinical research; and
healthcare financing. In addition, people with HIV and affected
populations, as well as state and local health and education agencies,
HIV/viral hepatitis/STD community-based organizations, and the ethics
or religious community are encouraged to submit nomination packages for
consideration. Current federal employees will not be considered.
Interested applicants may self-nominate or be nominated by another
individual or organization.
Individuals selected for appointment to CHACHSPT will be invited to
serve for up to 4 years. Members appointed as SGEs receive a stipend
and reimbursement for per diem and travel expenses incurred for
attending CHACHSPT meetings and/or conducting other business on behalf
of the CHACHSPT as authorized by 5 U.S.C. 5703 of the Federal Travel
Regulation for persons employed intermittently in government service.
The following information must be included in the package of
materials submitted for each individual nominated for consideration:
A letter of interest or personal statement from the
nominee stating how their expertise would inform the work of CHACHSPT;
A biographical sketch of the nominee (500 words or fewer);
A copy of the nominee's resume or curriculum vitae; and
The nominee's contact information (address, daytime
telephone number, and email address).
[[Page 69755]]
Nomination packages may be submitted directly by the individual
seeking nomination or by the person/organization recommending the
candidate. HRSA will collect and retain nomination packages to create a
pool of potential future CHACHSPT members. When a vacancy occurs, HRSA
will review nomination packages and may contact nominees at that time.
Nominations should be updated and resubmitted every two years for
continuing consideration for CHACHSPT vacancies.
Appointments shall be made without discrimination on the basis of
age, ethnicity, gender, sexual orientation, or cultural, religious, or
socioeconomic status.
Individuals who are selected for appointment will be required to
provide detailed information regarding their financial interests and,
for example, any work they do for the federal government through
research grants or contracts. Disclosure of this information is
required in order for HRSA ethics officials to determine whether there
is a conflict between the SGE's public duties as a member of CHACHSPT
and their private interests, including an appearance of a loss of
impartiality as defined by federal laws and regulations, and to
identify any required remedial action needed to address the potential
conflict.
Authority: CHACHSPT was established under Section 222 of the
Public Health Service (PHS) Act, [42 U.S.C. 217a], as amended.
CHACHSPT is governed by the provisions of the Federal Advisory
Committee Act, as amended, 5 U.S.C. App., which sets forth
requirements for the formation and use of advisory committees.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2019-27301 Filed 12-18-19; 8:45 am]
BILLING CODE 4165-15-P
